Octagon Capital
Overview
A multi-stage investment manager founded in 2019 that is dedicated to evidence-based investing in public and private healthcare companies, with a focus on the United States and China. The firm strives to build concentrated, long-term investments and partners with its portfolio companies. It manages capital for global institutions such as university endowments, non-profit foundations, family offices, and pension funds.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Abogen Biosciences | Aug 2021 | Series C | Co-investor |
| Edge Medical Robotics | Nov 2021 | Series C | Co-investor |
| Numab Therapeutics | Jan 2025 | Series C Extension | - |
| Aktis Oncology | Sep 2024 | Series B | Co-investor |
| EpimAb Biotherapeutics | Mar 2021 | Series C | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Octagon Capital based?
Headquarters information for Octagon Capital is not publicly available.
When was Octagon Capital founded?
Octagon Capital was founded in 2019.
How many portfolio companies does Octagon Capital have?
Octagon Capital has 26 portfolio companies in Caplight's dataset.
What are some companies in Octagon Capital's portfolio?
Portfolio companies visible on Caplight include Abogen Biosciences, Edge Medical Robotics, Numab Therapeutics, Aktis Oncology, EpimAb Biotherapeutics.
What was Octagon Capital's most recent investment shown here?
Octagon Capital's most recent investment in this portfolio sample was in Numab Therapeutics in 2025.
What sectors does Octagon Capital focus on?
Octagon Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Octagon Capital focus on?
Octagon Capital typically invests at the Mid stage.
What is Octagon Capital's AUM?
Octagon Capital's assets under management are estimated between $500.0M and $1.0B.